Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

PURPOSE: Oxaliplatin-induced peripheral neurotoxicity (OPN) is frequent and potentially severe, but successful treatment of this condition is still an unmet clinical need. We aimed to determine whether treatment with goshajinkigan (TJ-107), a traditional Japanese medicine, is better than placebo in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kono, Toru, Hata, Taishi, Morita, Satoshi, Munemoto, Yoshinori, Matsui, Takanori, Kojima, Hiroshi, Takemoto, Hiroyoshi, Fukunaga, Mutsumi, Nagata, Naoki, Shimada, Mitsuo, Sakamoto, Junichi, Mishima, Hideyuki
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2013
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3834178/
https://ncbi.nlm.nih.gov/pubmed/24121454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2306-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items